Women’s Health

Women’s health, including access to contraception and menopause services, is a key focus for us.
Women’s Health

Latest Development in Women's Health

Across the Wakefield District, we want to make sure that all our GPs and clinicians are kept up to date with the latest developments in women’s health in primary care.

This page provides resources and links to the latest guidance and training. It is mainly for health and care professionals but we also know that many women take an active role in looking after themselves and so this information is available for anyone to read.

If you would like to contact the team or have an idea that you you think could be considered by the Women’s Health leads, please email:
wyicb-wak.wakefield-womenshealth@nhs.net

Case Studies

The Women’s Health Leads Group was established to strengthen and share learning and knowledge across the district. The meetings themselves provide the opportunity to discuss complex cases and symptoms leading to possible treatments and solutions for patients. We are starting to capture the key point of these discussions to create Case Studies which will enable us to share this learning with the aim of speedier diagnosis and treatment for women across the district – and beyond!

GP Practice Documentation

We are developing GP Practice Pathway Documentation which sets out service and delivery requirements.

Menopause Mentoring Programme

FSRH Essential Contraception Following Childbirth Course

UK Preconception Partnership

Other Resources

The College of Sexual and Reproductive Health recently released updated Medical Eligibility Criteria for Contraception prescribing, the UKMEC 2025. Here are links to a summary of what’s new:

Changes include new evidence of a small increased risk of venous thromboembolism (VTE) with Medroxyprogesterone Acetate contraceptive injection (DMPA, Depo Provera and Sayana Press). A full risk assessment for VTE is recommended for patients commencing or having repeat DMPA and Sayana injections. Patients with multiple risk factors for VTE will now be a UKMEC 3 meaning the risks outweigh the benefits for most patients.

Please consult the links above for more details including other important changes which may affect your contraception prescribing.

Upcoming dates for your diary: coil fitters’ forum: implant fitters’ forum Wednesday 22nd April 7-8pm.

To book LARC forums please email Bryony.Senior@spectrum-cic.nhs.uk

BMS Tools for Clinician

Use of HRT in women using weight loss drugs

In This Together – Cervical Screening Project

We are reaching out from the In This Together – Cervical Screening Project to offer free community training sessions designed to support staff and volunteers who work with women and people with a cervix from marginalised or underserved communities.

The training aims to:

Sessions are interactive, community-friendly, and can be delivered in person or online. We particularly welcome participation from groups working with ethnic minorities, refugees and asylum seekers, people with learning disabilities, LGBTQ+ communities, and others who may face barriers to screening.

If your organisation would like to book a session or find out more, please get in touch with us at mandi.reeve@groundwork.org.uk and Fouizy.asim@groundwork.org.uk

Together, we can help ensure everyone feels informed, supported, and confident to attend their cervical screening when invited.

Rise in Syphilis Cases and Ceftriaxone Resistant Gonorrhoea

This is generally a lesser issue for Primary Care. However there is a high prevalence in the prison population and amongst female sex workers. This is the picture for Wakefield services but it also seems to be a widespread issue across the country.

Syphilis is ‘the great pretender’. There are cases where young women with oral lesions have been referred to maxillary-facial and skin rashes referred to dermatology as well as vulval lesions who have later tested positive for syphilis. Some are quite unwell.

It is present in the Wakefield general population also.

There is also a rising issue with antibiotic ceftriaxone resistant gonorrhoea